Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 166.50
-1.00 (-0.60%)
At close: Feb 12, 2026
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 142.24 million as of February 12, 2026. Its market cap has increased by 22.83% in one year.
Market Cap
142.24M
Enterprise Value
132.99M
Revenue
34.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
166.50
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 142.24M, an increase of 114.04%. That is a compound annual growth rate of 11.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 142.24M | 30.87% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Tristel | 204.62M |
| Animalcare Group | 194.02M |
| Faron Pharmaceuticals Oy | 191.04M |
| Optima Health | 189.54M |